CFTR and cystic fibrosis: Similarly to the main analysis, participants with CFRD in this subgroup presented more often with EPI and with 2 severe CFTR mutations than the participants from the CF control group (100% vs. 63%, p = 0.0001; and 97% vs. 72%, p = 0.01).